COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,026 Articles (22,627 medRxiv, 8,399 bioRxiv)

Most recent first Previous |  Page 2687: Articles 26861-26870  | Next

Drug treatments affecting ACE2 in COVID-19 infection: a systematic review protocol
Dambha-Miller, H., Albasri, A., Hodgson, S., Wilcox, C., Islam, N., Khan, S., Little, P., Griffin, S. J.
10.1101/2020.05.25.20100438 — Posted: 2020-05-26
The lower COVID-19 related mortality and incidence rates in Eastern European countries are associated with delayed start of community circulation
Ylli, A., Wu, Y. Y., Burazeri, G., Pirkle, C. M., Sentell, T.
10.1101/2020.05.22.20110148 — Posted: 2020-05-26
Prioritizing COVID-19 tests based in Participatory Surveillance and Spatial Scanning.
Leal Neto, O. B., Santos, F. A., Lee, J. Y., Albuquerque, J., Souza, W. V.
10.1101/2020.05.25.20109058 — Posted: 2020-05-26
Performance evaluation of the point-of-care SAMBA II SARS-CoV-2 Test for detection of SARS-CoV-2
Assennato, S. M., Ritchie, A. V., Nadala, C., Zhang, H., Datir, R., Gupta, R. K., Curran, M. D., Lee, H. H., Goel, N.
10.1101/2020.05.24.20100990 — Posted: 2020-05-26
Mechanistic rationale of drugs, Primary endpoints, Geographical distribution of clinical trials against Severe acute respiratory syndrome-related coronavirus-2: A Systematic Review
Venkatesulu, B. P., Thoguluva Chandrasekar, V., Giridhar, P., V, P., Patel, H., Manteuffel, J.
10.1101/2020.05.24.20112169 — Posted: 2020-05-26
MACHINE LEARNING PREDICTION FOR COVID 19 PANDEMIC IN INDIA
Ogundokun, R. O., Awotunde, J. B.
10.1101/2020.05.20.20107847 — Posted: 2020-05-26
Study on the expression levels of antibodies against SARS-CoV-2 at different period of disease and its related factors in 192 cases of COVID-19 patients
Ou, J., Tan, M., He, H., Tan, H., Mai, J., Long, Y., Jiang, X., He, Q., Huang, Y., Li, Y., Chen, R., Li, L., Li, F., Shi, Y.
10.1101/2020.05.22.20102525 — Posted: 2020-05-26
Risk of infection and hospitalization by Covid-19 in Mexico: a case-control study
Berumen, J., Schmulson, M., Alegre, J., Guerrero, G., Olaiz, G., Wong-Chew, R. M., Larriva-Sahd, J., Cantu-Brito, C., Ochoa-Guzman, A., Garcilazo-Avila, A., Gonzalez-Carballo, C., Chiquete, E.
10.1101/2020.05.24.20104414 — Posted: 2020-05-26
COVID-19 knowledge, risk perception and precautionary behaviour among Nigerians: A moderated mediation approach
Iorfa, S. K., Ottu, I. F. A., Oguntayo, R., Ayandele, O., Kolawole, S. O., Gandi, J. C., Dangiwa, A. L., Olapegba, P. O.
10.1101/2020.05.20.20104786 — Posted: 2020-05-26
A Noncooperative Game Analysis for Controlling COVID-19 Outbreak
Bairagi, A. K., Masud, M., Kim, D. H., Munir, M. S., Nahid, A. A., Abedin, S. F., Alam, K. M., Biswas, S., Alshamrani, S. S., Han, Z., Hong, C. S.
10.1101/2020.05.22.20110783 — Posted: 2020-05-26

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).